UMLS - Terms starting with ‘U’

	Medical glossary.
	MEDINDEX.AM UMLS About Catalog. Medical sites. UMLS.Semantic Types. Feedback

%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z a c d e g h i

B B B0 B1 B2 B3 B4 B6 B7 B8 BA BB BC BD BE BF BG BH BI BK BL BM BN BO BP BR BS BT BU BV BW BX BY BZ

BUB BUC BUD BUE BUF BUG BUI BUL BUM BUN BUP BUR BUS BUT BUV BUZ

selected terms: 1,430

1 2 3 4 .. 15 Next >>

page 1 of 15

1,3-Butadiene: [A synthetic, colorless gas that is practically insoluble in water and soluble in ethanol, ether, acetone and benzene. It is used primarily as a monomer to manufacture many different types of polymers and copolymers and as a chemical intermediate in the production of industrial chemicals. When heated, 1,3-butadiene emits acrid fumes and is flammable. In the presence of air, it oxidizes to form explosive peroxides. The primary route of potential human exposure to this compound is inhalation. Acute exposure to 1,3-butadiene can cause irritation of the eyes, nasal passages and throat. At very high concentrations, inhalation of this gas can result in headache, fatigue, decreased blood pressure and pulse rate, central nervous system damage and unconsciousness. It is known to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0043902) =Organic Chemical; Hazardous or Poisonous Substance ;;
1,3-BUTYL GLYC/ISOPROPANOL SOLUTION, NON-ORAL: [ ] (UMLS (RXNORM) C1350635) 1,3-BUTYLENE GLYCOL/ISOPROPYL ALCOHOL SOLUTION, NON-ORAL =Clinical Drug
1,5-(butylimino)-1,5-dideoxy-D-glucitol: [A synthetic, N-alkylated imino analogue of D-glucose. Miglustat competitively and reversibly binds to and inhibits the activity of UDP-glucose ceramide glucosyltransferase, which catalyzes the initial step in the synthesis of glycosphingolipids (GSL). This leads to a decrease in the production of glycosphingolipid, which has important roles in various cellular processes. Miglustat can be used in substrate reduction therapy in diseases in which the enzyme glucocerebrosidase, that is responsible for the breakdown of GSL, is deficient. ( NCI )] (UMLS (NCI) C1321596) 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-,(2R-(2alpha,3beta,4alpha,5beta))-;;MIGLUSTAT;;MIGLUSTAT PREPARATION;;N-Butyl Deoxynojirimycin;;N-Butylmoranoline =Organic Chemical; Pharmacologic Substance =[HS900] HORMONES/SYNTHETICS/MODIFIERS, OTHER;;Unclassified Ingredients =MIGLUSTAT 100 MG
1-Butanone, 1-(4-fluorophenyl)-4-[4-[(4-fluorophenyl)hydroxymethyl]-1-piperidi nyl]-: [A butyrophenone that has been investigated for antineoplastic activity. (NCI04) ( NCI )] (UMLS (NCI) C0208317) =Organic Chemical; Pharmacologic Substance ;;
2-Butenoic acid, 3-bromo-4-(4-methoxyphenyl)-4-oxo-, sodium salt, (Z)- (9CI): (UMLS (NCI) C0893303) Acrylic acid, 3-p-anisoyl-3-bromo-, sodium salt;;Sodium Bromebrate;;Sodium cis-Beta-4-methoxybenzoyl-beta-bromacrylate =Organic Chemical; Pharmacologic Substance
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol: [antihypertensive agent; nonpeptide angiotension 1 subtype; angiotension 2 receptor antagonist/inhibitor. ( CSP )] (UMLS (NCI) C0126174) =Organic Chemical; Pharmacologic Substance ;; =antihypertensive agent;;biphenyl compound;;imidazole;;Tetrazoles;;[CV805] ANGIOTENSIN II INHIBITORS;; =2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, Monopotassium Salt;;LOSARTAN 25 MG;;LOSARTAN 50 MG
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, Monopotassium Salt: [The potassium salt form of losartan, a non-peptide angiotensin II antagonist with antihypertensive activity. Losartan potassium selectively and competitively blocks the binding of angiotensin II to the angiotensin I (AT1) receptor. Angiotensin II, formed from angiotensin I by angiotensin-converting enzyme (ACE), stimulates the adrenal cortex to synthesize and secrete aldosterone, which decreases the excretion of sodium and increases the excretion of potassium. Angiotensin II also acts as a vasoconstrictor in vascular smooth muscle. Losartan potassium, by blocking the binding of angiotensin II to the AT 1 receptor, promotes vasodilatation and decreases the effects of aldosterone. ( NCI )] (UMLS (NCI) C0700492) =Organic Chemical; Pharmacologic Substance ;; =2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol;; =LOSARTAN POTASSIUM 25 MG;;LOSARTAN POTASSIUM 50 MG;;LOSARTAN POTASSIUM 100 MG;;
5-[[2-(2-Butoxyethoxy)ethoxy]methyl]-6-propyl-1,3-benzodioxole: [A synthetic derivative of benzodioxole and used as an insecticide synergist, Piperonyl Butoxide enhances the active properties of pyrethrin, pyrethroid, rotenone, and carbamate pesticide ingredients by inhibiting insect microsomal enzyme detoxification activity. It is toxic and suspected of causing anorexia, carcinogenesis, convulsions, and dermal irritation, as well as hepatic and renal damage. (NCI04) ( NCI )] (UMLS (NCI) C0031962) =Organic Chemical; Hazardous or Poisonous Substance =Dioxoles;;Pediculicide =PIPERONYL BUTOXIDE TECHNICAL;;PIPERONYL BUTOXIDE 3 %;;
BU/CPFX/CTX/PTX: (UMLS (NCI) C0281474) =Therapeutic or Preventive Procedure
BU/CPFX/L-PAM/PTX/TSPA: (UMLS (NCI) C0281476) =Therapeutic or Preventive Procedure
BU/CTX: (UMLS (NCI) C0278611) =Therapeutic or Preventive Procedure
BU/CTX/DAC: (UMLS (NCI) C0393038) =Therapeutic or Preventive Procedure
BU/CTX/DHAD: (UMLS (NCI) C0281391) =Therapeutic or Preventive Procedure ;;
BU/CTX/IFN-A/ZDV: (UMLS (NCI) C0338174) =Therapeutic or Preventive Procedure
BU/CTX/MePRDL: (UMLS (NCI) C0678058) =Therapeutic or Preventive Procedure ;;
BU/CTX/TSPA: (UMLS (NCI) C0281597) =Therapeutic or Preventive Procedure ;;
BU/CTX/VP-16: (UMLS (NCI) C0278706) =Therapeutic or Preventive Procedure
BU/DHAD: (UMLS (NCI) C0280742) =Therapeutic or Preventive Procedure
BU/DM/TSPA: (UMLS (NCI) C0338241) =Therapeutic or Preventive Procedure
BU/IFN-A: (UMLS (NCI) C0338169) =Therapeutic or Preventive Procedure
BU/L-PAM: (UMLS (NCI) C0279844) =Therapeutic or Preventive Procedure
BU/L-PAM/MePRDL: (UMLS (NCI) C0678098) =Therapeutic or Preventive Procedure
BU/L-PAM/TSPA: (UMLS (NCI) C0281475) =Therapeutic or Preventive Procedure
BU/TSPA: (UMLS (NCI) C0281472) =Therapeutic or Preventive Procedure
BU/VP-16: (UMLS (NCI) C0281160) =Therapeutic or Preventive Procedure ;;
BUB/BnJ: (UMLS (NCI) C1511031) BUB/BnJ Mouse;; =Mammal; ;;
BUB1: [This gene is a modulator of the mitotic spindle cell cycle checkpoint. ( NCI )] (UMLS (NCI) C1332455) BUB1 Budding Uninhibited by Benzimidazoles 1 Homolog Gene;;BUB1 Gene;; =Gene or Genome ;; ◊ [BUB1 Budding Uninhibited by Benzimidazoles 1 Homolog (Yeast), encoded by the human BUB1 gene, is a 120-kD serine/threonine protein kinase. This protein monitors the attachment of chromosomes to spindle poles and may be a component of the mitotic checkpoint that delays anaphase until all chromosomes are properly attached to the mitotic spindle. As part of a common complex in checkpoint-activated cells, Bub1 monitors different spindle events compared to BubR1 and integrates different signals into a single signal that is then relayed to the downstream cell cycle machinery. It interacts with Bub3, CENP-F, CENP-E and mitosin. The BUB1 gene is highly expressed in thymus followed by spleen. Defects in Bub1 are associated with tumor formation. (From LocusLink, Swiss_Prot and NCI) ( NCI )] (UMLS (NCI) C1332456) BUB1 Budding Uninhibited by Benzimidazoles 1 Homolog;;BUB1 Budding Uninhibited by Benzimidazoles 1 Homolog (Yeast);; Amino Acid, Peptide, or Protein; Enzyme
BUB1 Budding Uninhibited by Benzimidazoles 1 Homolog wt Allele: [Human BUB1 wild-type allele is located in the vicinity of 2q14 and is approximately 40 kb in length. This allele, which encodes mitotic checkpoint serine/threonine-protein kinase BUB1 protein, is involved in the regulation of spindle checkpoints and mitotic integrity. Mutations in this gene, which generate allelic variants have been associated with aneuploidy and several forms of cancer. ( NCI )] (UMLS (NCI) C1706906) BUB1 wt Allele;;BUBR1 Gene;;hBUB1 Gene;;MAD3L Gene =Gene or Genome ;;
Bubble Detector: (UMLS (NCI) C1707057) Bubble Detector Device Component;; =Medical Device ;;
Bubbli-Pred: [ ] (UMLS (RXNORM) C1633712) =Steroid; Pharmacologic Substance
Bubbli-Pred 1 MG/ML Oral Solution: [ ] (UMLS (RXNORM) C1631143) (prednisolone 1 MG/ML Oral Solution [Bubbli-Pred]) prednisolone 1 MG/ML Oral Solution [Bubbli-Pred] =Clinical Drug ;;
Bubo: (UMLS (HL7) C1546567) =Intellectual Product =Specimen Source Codes;;
BUCC: [Administration directed toward the cheek, generally from within the mouth. (FDA) ( NCI )] (UMLS (NCI) C1522188) Buccal;;Buccal Route of Administration =Functional Concept; ;; =drug administration route;;
bucca: [ ] (UMLS (CSP) C0007966) =Body Location or Region ;; =Body Part;;
Buccal: (UMLS (HL7) C0442010) =Spatial Concept =Body Part;;
Buccal: [The surface of the tooth facing or in direct contact with the oral mucosa of the cheek. ( NCI )] (UMLS (NCI) C1540415) Buccal Surface;; =Body Location or Region; ;;
Buccal Artery: (UMLS (NCI) C0226151) =Body Part, Organ, or Organ Component
Buccal Capsule Dosage Form: [A capsule for buccal use. ( NCI )] (UMLS (NCI) C1879900) Buccal Capsule Dose Form;; =Manufactured Object
Buccal Cavity: [oval shaped oral cavity located at the apex of the digestive tract. ( CSP )] (UMLS (NCI) C0226896) =Body Space or Junction =Body Part;;oral pharyngeal =lip;;mouth mucosa;;Lingual;;palate;;
buccal mucosa: [(BUK-ul myoo-KO-sa) The inner lining of the cheeks and lips. ( NCI )] (UMLS (NCI) C1578559) =Body Part, Organ, or Organ Component ;;
Buccal Mucosa Neoplasm: (UMLS (NCI) C0345563) =Neoplastic Process
Buccal Mucosa Papilloma: (UMLS (NCI) C1332641) Papilloma of Buccal Mucosa;;Papilloma of the Buccal Mucosa;; =Neoplastic Process ;;
Buccal Mucosa Squamous Cell Carcinoma: (UMLS (NCI) C0280299) =Neoplastic Process
Buccal Mucosa Verrucous Carcinoma: (UMLS (NCI) C0280307) =Neoplastic Process
Buccal Salivary Gland: (UMLS (NCI) C0930555) =Body Part, Organ, or Organ Component
Buccal Tablet: [ ] (UMLS (RXNORM) C0991502) =Biomedical or Dental Material =Oral Tablet;; =Sustained Release Buccal Tablet
Buccal Tablet Dosage Form: [A small flat tablet to be administered by placing it between the cheek and gum, permitting the direct absorption through the oral mucosa of the medicinal substance contained therein. ( NCI )] (UMLS (NCI) C1707058) Buccal Tablet Dose Form;; =Manufactured Object ;;
BuccalMucosaRoute: [Buccal mucosa ( HL7V3.0 )] (UMLS (HL7) C1698336) =Functional Concept ;; =RouteBySite;; =Topical application, buccal
Buccalsone: (UMLS (NCI) C1512526) =Steroid; Pharmacologic Substance
Buccinator: (UMLS (NCI) C0224121) =Body Part, Organ, or Organ Component
Bucconeural Duct: [The slender tubular part of the hypophysial diverticulum; the stalk of Rathke's pocket. ( NCI )] (UMLS (NCI) C0229549) =Body Part, Organ, or Organ Component
Buchu: [ ] (UMLS (RXNORM) C0771815) =Organic Chemical; Pharmacologic Substance ;;
BUCHU 65 MG Oral (systemic) tablet: [ ] (UMLS (RXNORM) C0691229) =Clinical Drug
Buchu Oral Tablet: [ ] (UMLS (RXNORM) C1248983) =Clinical Drug
BUCHU,JUNIPER&POT ACETATE ELIXIR: [ ] (UMLS (RXNORM) C1351597) =Clinical Drug
BUCHU,JUNIPER&POT ACETATE MISCELLANEOUS: [ ] (UMLS (RXNORM) C1360417) =Pharmacologic Substance
BUCHU,JUNIPER&POT ACETATE TABLET: [ ] (UMLS (RXNORM) C1358411) =Clinical Drug
BUCHU/BEARBERRY 100-200MG CAPSULE (HARD, SOFT, ETC.): [ ] (UMLS (RXNORM) C1340168) BUCHU/BEARBERRY 100-200MG CAPSULE (HARD, SOFT, ETC.);; =Clinical Drug
BUCK/PEP/W-YM/CAY/YELLOW DK/GI CAPSULE (HARD, SOFT, ETC.): [ ] (UMLS (RXNORM) C1339391) BUCKTHORN/PEPPERMINT/WILD YAM/CAYEN/YELLOW DK/GING/FEN/RHUB CAPSULE (HARD, SOFT, ETC.);;BUCKTHORN/PEPPERMINT/WILD YAM/CAYEN/YELLOW DK/GING/FEN/RHUB CAPSULE (HARD, SOFT, ETC.);; =Clinical Drug
BUCKBEAN/GENT/PEP/CENTAU/YARR/ DROPS: [ ] (UMLS (RXNORM) C1353579) BUCKBEAN/GENTIAN/PEPPERMINT/CENTAURY/YARROW/WORMWOOD DROPS =Clinical Drug
Bucket handle tear of lateral meniscus: [ ] (UMLS (ICD9CM) C0434992) =Injury or Poisoning
Buckeyball: [A nanoparticle characterized by a spherical geometry and hollow interior that is comprised of 60 carbon atoms. This configuration is the most common type of fullerene. ( NCI )] (UMLS (NCI) C1879902) Buckyball;; =Classification
Buckland: (UMLS (NCI) C1551805) =Population Group =Inupiat Eskimo;;
Buckled material: (UMLS (NCI) C1879901) Buckled Medical Device Material;; =Phenomenon or Process
Buckley's Bedtime Formula: [ ] (UMLS (RXNORM) C1879120) =Organic Chemical; Pharmacologic Substance
Buckley's DM Cough Suppressant: [ ] (UMLS (RXNORM) C1879128) =Organic Chemical; Pharmacologic Substance
Buckley's DM Cough Suppressant 2.5 MG/ML Oral Suspension: [ ] (UMLS (RXNORM) C1877343) (Dextromethorphan 2.5 MG/ML Oral Suspension [Buckley's DM Cough Suppressant]) Dextromethorphan 2.5 MG/ML Oral Suspension [Buckley's DM Cough Suppressant] =Clinical Drug
Buckley's DM Decongestant: [ ] (UMLS (RXNORM) C1170109) =Organic Chemical; Pharmacologic Substance ;;
Buckleys: [ ] (UMLS (RXNORM) C1589647) =Pharmacologic Substance
Buckleys Formo Cresol: [ ] (UMLS (RXNORM) C1589651) =Pharmacologic Substance
Buckleys Mixture: [ ] (UMLS (RXNORM) C1815116) =Organic Chemical; Pharmacologic Substance ;;
Buckleys Mixture 2.5 MG/ML Oral Solution: [ ] (UMLS (RXNORM) C1813278) (Dextromethorphan 2.5 MG/ML Oral Solution [Buckleys Mixture];;) Dextromethorphan 2.5 MG/ML Oral Solution [Buckleys Mixture];; =Clinical Drug ;;
BUCKT BK/CENTAURY/BLADDERWRACK TABLET: [ ] (UMLS (RXNORM) C1358808) BUCKTHORN BARK/CENTAURY/BLADDERWRACK TABLET =Clinical Drug
BUCKTHORN BARK 170MG CAPSULE (HARD, SOFT, ETC.): [ ] (UMLS (RXNORM) C1339565) BUCKTHORN BARK 170MG CAPSULE (HARD, SOFT, ETC.);; =Clinical Drug
BUCKTHORN BARK 250MG CAPSULE (HARD, SOFT, ETC.): [ ] (UMLS (RXNORM) C1339564) BUCKTHORN BARK 250MG CAPSULE (HARD, SOFT, ETC.);; =Clinical Drug
BUCKTHORN BARK 75MG TABLET: [ ] (UMLS (RXNORM) C1360196) =Clinical Drug
BUCKTHORN BARK TEA (GM): [ ] (UMLS (RXNORM) C1350327) =Food
BUCKTHORN BARK/ANISEED/FENNEL TEA (EA): [ ] (UMLS (RXNORM) C1348514) BUCKTHORN BARK/ANISEED/FENNEL TEA (EA);; =Food
BUCKTHORN FRUIT 125MG TABLET: [ ] (UMLS (RXNORM) C1359276) =Clinical Drug
Buckthorn preparation: [ ] (UMLS (RXNORM) C1095907) =Organic Chemical; Pharmacologic Substance
Buckthorn preparation 50 MG: [ ] (UMLS (RXNORM) C1382203) =Clinical Drug
BUCKTHORN/DANDELION/CHICKWEED TEA (EA): [ ] (UMLS (RXNORM) C1348509) BUCKTHORN/DANDELION/CHICKWEED TEA (EA);; =Food
BUCKTHORN/YELLOW DOCK/CLOVE 12-172-33 TABLET: [ ] (UMLS (RXNORM) C1357858) =Clinical Drug
BUCLIZINE: (UMLS (NCI) C0164386) =Organic Chemical; Pharmacologic Substance ;; =Piperazines;;[CN550] ANTIVERTIGO AGENTS =Buclizine Hydrochloride
buclizine / Hydroxyzine / Niacin Oral Tablet: [ ] (UMLS (RXNORM) C1367440) =Clinical Drug
buclizine / Vitamin B6 Oral Tablet: [ ] (UMLS (RXNORM) C1704130) =Clinical Drug
buclizine 1 MG/ML: [ ] (UMLS (RXNORM) C1128972) =Clinical Drug
buclizine 12.5 MG: [ ] (UMLS (RXNORM) C1367439) =Clinical Drug
buclizine 12.5 MG / Hydroxyzine 10 MG / Niacin 25 MG Oral Tablet: [ ] (UMLS (RXNORM) C1360269) BUCLIZINE HCL/HYDROXYZ HCL/NIA 12.5-10-25 TABLET;;BUCLIZINE HCL/HYDROXYZINE HCL/NIACIN 12.5-10-25 TABLET =Clinical Drug
buclizine 25 MG: [ ] (UMLS (RXNORM) C1128973) =Clinical Drug
buclizine 50 MG: [ ] (UMLS (RXNORM) C1124896) =Clinical Drug
buclizine 50 MG Chewable Tablet: [ ] (UMLS (RXNORM) C0975059) BUCLIZINE HCL 50MG TAB,CHEWABLE;; =Clinical Drug ;; =BUCLIZINE HYDROCHLORIDE 50 MG;;
buclizine 50 MG Oral Tablet: [ ] (UMLS (RXNORM) C0783129) BUCLIZINE HCL 50MG TABLET;;BUCLIZINE HCL 50MG ORAL TABLET;;BUCLIZINE HCL 50MG TABLET;;Buclizine HCl Tab 50 MG;;BUCLIZINE HCL50MGORALTABLET;; =Clinical Drug
buclizine 6.25 MG: [ ] (UMLS (RXNORM) C1366551) =Clinical Drug
buclizine Chewable Tablet: [ ] (UMLS (RXNORM) C1249916) =Clinical Drug
BUCLIZINE HCL/PYRIDOXINE 25-50MG TABLET: [ ] (UMLS (RXNORM) C1703751) (Buclizine-Pyridoxine Tab 25-50 MG) Buclizine-Pyridoxine Tab 25-50 MG =Clinical Drug
Buclizine Hydrochloride: (UMLS (NCI) C0304304) =Organic Chemical; Pharmacologic Substance ;; =BUCLIZINE;; =BUCLIZINE HYDROCHLORIDE 50 MG
BUCLIZINE HYDROCHLORIDE 50 MG: (UMLS (NDFRT)) (C1380059) =Clinical Drug =Buclizine Hydrochloride;; =buclizine 50 MG Chewable Tablet;;
buclizine Oral Tablet: [ ] (UMLS (RXNORM) C1245186) =Clinical Drug
buclizine Syrup: [ ] (UMLS (RXNORM) C1245185) =Clinical Drug

UMLS

1 2 3 4 .. 15 Next >>

MEDINDEX.AM

to main page

About • Catalog. Medical sites. • UMLS.Semantic Types. • Feedback

top of page